Cancer Medicine (Jan 2023)
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study
- Angelina K. C. Fink,
- Amanda C. DeRenzis,
- Shivanshu Awasthi,
- Nawreen Jahan,
- Peter A. S. Johnstone,
- Julio Pow‐Sang,
- Javier Torres‐Roca,
- Daniel Grass,
- Daniel Fernandez,
- Arash Naghavi,
- Susan Tan,
- Brandon Manley,
- Roger Li,
- Michael Poch,
- Alice Yu,
- Nikki Little,
- Eppie Bass,
- Cesar E. Ercole,
- Evangelia Katsoulakis,
- Ryan Burri,
- Riley Smith,
- Nathanael B. Stanley,
- Susan T. Vadaparampil,
- Kosj Yamoah
Affiliations
- Angelina K. C. Fink
- Cancer Epidemiology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Amanda C. DeRenzis
- Cancer Epidemiology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Shivanshu Awasthi
- Cancer Epidemiology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Nawreen Jahan
- Tallahassee Memorial Hospital Tallahassee Florida USA
- Peter A. S. Johnstone
- Radiation Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Julio Pow‐Sang
- Genitourinary Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Javier Torres‐Roca
- Radiation Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Daniel Grass
- Radiation Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Daniel Fernandez
- Radiation Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Arash Naghavi
- Radiation Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Susan Tan
- Radiation Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Brandon Manley
- Genitourinary Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Roger Li
- Genitourinary Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Michael Poch
- Genitourinary Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Alice Yu
- Genitourinary Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Nikki Little
- Genitourinary Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Eppie Bass
- Genitourinary Oncology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Cesar E. Ercole
- Urology Section James A. Haley Veterans' Hospital Tampa Florida USA
- Evangelia Katsoulakis
- Radiation James A. Haley Veterans' Hospital Tampa Florida USA
- Ryan Burri
- Radiation Bay Pines VA Healthcare System Bay Pines Florida USA
- Riley Smith
- Cancer Epidemiology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Nathanael B. Stanley
- Office of Community Outreach, Engagement & Equity (COEE) H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Susan T. Vadaparampil
- Office of Community Outreach, Engagement & Equity (COEE) H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- Kosj Yamoah
- Cancer Epidemiology H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA
- DOI
- https://doi.org/10.1002/cam4.5000
- Journal volume & issue
-
Vol. 12,
no. 2
pp. 1869 – 1877
Abstract
Abstract Participation in cancer research trials by minority populations is imperative in reducing disparities in clinical outcomes. Even with increased awareness of the importance of minority patient inclusion in clinical research to improve cancer care and survival, significant barriers persist in accruing and retaining minority patients into clinical trials. This study sought to identify and address barriers to minority accrual to a minimal risk clinical research study in real‐time.
Keywords
